Heart:孤独与心血管事件之间的纵向联系

2020-06-20 MedSci原创 MedSci原创

该研究为孤独与心血管事件之间的关系提供了有力的证据。在心血管疾病的研究和干预措施中,孤独感应被视为CVD的社会心理危险因素。

近日,心脏病领域权威杂志Heart上发表了一篇研究文章,这项研究旨在评估孤独症、社会隔离和血管疾病(CVD)之间的关系,同时探究自我报告的CVD诊断和与CVD相关的住院人数。

该研究的数据来源于英国老年人纵向研究,并与行政医院记录和死亡登记数据相关联。用于分析自我报告CVD的分析样本量为5850人,从医院记录中提取的CVD样本为4587人,随访时间长达9.6年。研究人员使用生存分析对数据进行分析,以解决竞争风险事件。

受试者平均年龄为64岁(SD为8.3)。大约44%–45%是男性。在随访过程中,有17%的参与者报告有新诊断的CVD,16%的参与者为CVD相关住院。研究人员发现孤独与CVD事件的风险增加相关,而与潜在的混杂因素和风险因素无关。孤独感最强的人群CVD诊断的风险高出30%(HR:1.05,95%CI:1.01-1.09),而与CVD相关的住院治疗风险则高出48%(HR:1.08,95%CI :1.03-1.14),相比于孤独感最小的人群。几乎没有证据表明社会隔离与CVD诊断或入院风险独立相关。

由此可见,该研究为孤独与心血管事件之间的关系提供了有力的证据。在心血管疾病的研究和干预措施中,孤独感应被视为CVD的社会心理危险因素。

原始出处:

Feifei Bu.et al.Longitudinal associations between loneliness, social isolation and cardiovascular events.heart.2020.https://creativecommons.org/licenses/by/4.0/

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=808232, encodeId=bad8808232ef, content=牛逼, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200620/aa639dfc8a1a4edf8fd1a054e00988dd/d30946ee96694a4f8aa034f2e536c052.jpg, createdBy=23f62697515, createdName=ms5000001417824766, createdTime=Wed Aug 12 17:18:08 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806736, encodeId=4911806e3670, content=这个杂志投稿周期多久?, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b58d5402080, createdName=咻凡, createdTime=Fri Aug 07 09:44:49 CST 2020, time=2020-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643705, encodeId=475c1643e056c, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Tue Mar 23 17:18:18 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357533, encodeId=d96c135e53317, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Jun 22 10:18:18 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563321, encodeId=66a11563321b7, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Mon Jun 22 10:18:18 CST 2020, time=2020-06-22, status=1, ipAttribution=)]
    2020-08-12 ms5000001417824766

    牛逼

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=808232, encodeId=bad8808232ef, content=牛逼, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200620/aa639dfc8a1a4edf8fd1a054e00988dd/d30946ee96694a4f8aa034f2e536c052.jpg, createdBy=23f62697515, createdName=ms5000001417824766, createdTime=Wed Aug 12 17:18:08 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806736, encodeId=4911806e3670, content=这个杂志投稿周期多久?, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b58d5402080, createdName=咻凡, createdTime=Fri Aug 07 09:44:49 CST 2020, time=2020-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643705, encodeId=475c1643e056c, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Tue Mar 23 17:18:18 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357533, encodeId=d96c135e53317, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Jun 22 10:18:18 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563321, encodeId=66a11563321b7, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Mon Jun 22 10:18:18 CST 2020, time=2020-06-22, status=1, ipAttribution=)]
    2020-08-07 咻凡

    这个杂志投稿周期多久?

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=808232, encodeId=bad8808232ef, content=牛逼, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200620/aa639dfc8a1a4edf8fd1a054e00988dd/d30946ee96694a4f8aa034f2e536c052.jpg, createdBy=23f62697515, createdName=ms5000001417824766, createdTime=Wed Aug 12 17:18:08 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806736, encodeId=4911806e3670, content=这个杂志投稿周期多久?, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b58d5402080, createdName=咻凡, createdTime=Fri Aug 07 09:44:49 CST 2020, time=2020-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643705, encodeId=475c1643e056c, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Tue Mar 23 17:18:18 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357533, encodeId=d96c135e53317, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Jun 22 10:18:18 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563321, encodeId=66a11563321b7, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Mon Jun 22 10:18:18 CST 2020, time=2020-06-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=808232, encodeId=bad8808232ef, content=牛逼, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200620/aa639dfc8a1a4edf8fd1a054e00988dd/d30946ee96694a4f8aa034f2e536c052.jpg, createdBy=23f62697515, createdName=ms5000001417824766, createdTime=Wed Aug 12 17:18:08 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806736, encodeId=4911806e3670, content=这个杂志投稿周期多久?, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b58d5402080, createdName=咻凡, createdTime=Fri Aug 07 09:44:49 CST 2020, time=2020-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643705, encodeId=475c1643e056c, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Tue Mar 23 17:18:18 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357533, encodeId=d96c135e53317, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Jun 22 10:18:18 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563321, encodeId=66a11563321b7, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Mon Jun 22 10:18:18 CST 2020, time=2020-06-22, status=1, ipAttribution=)]
    2020-06-22 zhaojie88
  5. [GetPortalCommentsPageByObjectIdResponse(id=808232, encodeId=bad8808232ef, content=牛逼, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200620/aa639dfc8a1a4edf8fd1a054e00988dd/d30946ee96694a4f8aa034f2e536c052.jpg, createdBy=23f62697515, createdName=ms5000001417824766, createdTime=Wed Aug 12 17:18:08 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806736, encodeId=4911806e3670, content=这个杂志投稿周期多久?, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b58d5402080, createdName=咻凡, createdTime=Fri Aug 07 09:44:49 CST 2020, time=2020-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643705, encodeId=475c1643e056c, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Tue Mar 23 17:18:18 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357533, encodeId=d96c135e53317, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Jun 22 10:18:18 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563321, encodeId=66a11563321b7, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Mon Jun 22 10:18:18 CST 2020, time=2020-06-22, status=1, ipAttribution=)]
    2020-06-22 slcumt

相关资讯

Semin Arthritis Rheu:颈动脉斑块可以预测类风湿性关节炎患者的心血管事件

存在颈动脉斑块可以预测RA患者的CV事件和死亡。在RA患者中颈动脉斑块和QRISK3的预测能力高于mSCORE。

Arthritis Rheumatol:生物制剂可以预防类风湿性关节炎的心血管事件

在类风湿性关节炎中,早期动脉粥样硬化患者使用bDMARD与CVD风险降低、非钙化病变的保护性钙化和新斑块形成的可能性降低相关。

Ann Rheum Dis:类风湿性关节炎对冠心病和非冠心病患者主要心血管事件的影响

在接受CAG的患者中,无论是否存在CAD,RA均与MI、MACE和全因死亡率的10年风险显著相关。

BMJ:普及富钾食盐可大幅降低中国心血管死亡风险

中国全国范围内的富钾食盐替代将带来可观的净效益,总体上可减少约九分之一的心血管疾病死亡。

JACC:阿托伐他汀可减少跨血管区域的首次和随后的血管不良事件

在SPARCL临床试验中,阿托伐他汀可减少近期中风或短暂性脑缺血发作且无已知冠心病患者的首次中风和首次复合血管事件的发生。这项事后分析的目的是评估SPARCL中所有(第一次和随后的)血管事件的发生率以

Heart:孤独、社会孤立与心血管事件之间的纵向联系

该研究的结果为孤独与心血管事件之间的关系提供了有力的证据。在研究和预防心血管疾病的干预措施中,应将孤独视为心血管疾病的社会心理危险因素。